The Slovenian concern KRKA is one of the world's leading manufacturers of generics. The products are produced in factories in Slovenia, Croatia, Poland, Germany and Russia. It is supplied to more than 70 countries. The company employs more than 12 000 employees, of which over 2 000 work in Russia. All of the company's products are produced in compliance with GMP international quality standards.
In 2003, PSO-13 built the first stage of the KRKA-RUS pharmaceuticals plant in Istra, near Moscow. The investment amounted to 40 million euros.
In 2013, PSO-13 completed construction of the second stage of the KRKA-RUS II plant and a new high-bay automated warehouse. Investments exceeded 135 million euros.
The KRKA-RUS plant currently produces more than 40 products. Products are exported to Belarus, Kazakhstan, Uzbekistan, Ukraine, Azerbaijan, Georgia, Kyrgyzstan, Moldova as well as to EU countries: Germany, Belgium, Ireland, Austria, Finland, Italy, France and Portugal.
The production capacity exceeds 2 billion tablets per year. The plant employs 490 people.
